Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kumpulainen

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|February 8, 2002
[Bisphosphonates in the therapy of cancer patients]E Jantunen, E Kumpulainen
Cellular and Molecular Biology|January 1, 1982
Comparative studies on the transport of isethionic acid and taurine in central nervous system (CNS)I Ikäheimo, E Kumpulainen, P Lähdesmäki
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Intraluminal and interstitial radiation therapy]E Kumpulainen, T Lahtinen, R Johansson
Neurochemical Research|August 1, 1982
Isethionate and taurine transport sites at brain cell membranes: influx studies with brain slicesI Ikäheimo, E Kumpulainen, P Lähdesmäki
Cellular and Molecular Biology, Including Cyto-Enzymology|January 1, 1979
Comparative studies on the interaction of amino acids with synaptosomes, synaptic vesicles and synpatic membranesA Karppinen, E Kumpulainen, P Lähdesmäki
Acta Physiologica Scandinavica|February 1, 1979
Synaptosomal accumulation of intracerebrally injected amino acidsA Karppinen, E Kumpulainen, P Lähdesmäki
Advances in Biochemical Psychopharmacology|January 1, 1981
The terms "high affinity" and "high capacity" as conceptions in the interaction of amino acids with synaptic membranesP Lähdesmäki, I Pesonen, E Kumpulainen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of metastatic carcinoid tumour with recombinant interferon alfaH Joensuu, E Kumpulainen, P Gröhn
Acta Physiologica Scandinavica|March 1, 1982
Exchange of isethionate between blood and tissues in adult and 7-day-old miceE Kumpulainen, I Pesonen, P Lähdesmäki
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Response of medullary thyroid cancer to low-dose alpha-interferon therapyP Gröhn, E Kumpulainen, M Jakobsson
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Duodecim; Laaketieteellinen Aikakauskirja|February 8, 2002
[Bisphosphonates in the therapy of cancer patients]E Jantunen, E Kumpulainen
Cellular and Molecular Biology|January 1, 1982
Comparative studies on the transport of isethionic acid and taurine in central nervous system (CNS)I Ikäheimo, E Kumpulainen, P Lähdesmäki
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Intraluminal and interstitial radiation therapy]E Kumpulainen, T Lahtinen, R Johansson
Neurochemical Research|August 1, 1982
Isethionate and taurine transport sites at brain cell membranes: influx studies with brain slicesI Ikäheimo, E Kumpulainen, P Lähdesmäki
Cellular and Molecular Biology, Including Cyto-Enzymology|January 1, 1979
Comparative studies on the interaction of amino acids with synaptosomes, synaptic vesicles and synpatic membranesA Karppinen, E Kumpulainen, P Lähdesmäki
Acta Physiologica Scandinavica|February 1, 1979
Synaptosomal accumulation of intracerebrally injected amino acidsA Karppinen, E Kumpulainen, P Lähdesmäki
Advances in Biochemical Psychopharmacology|January 1, 1981
The terms "high affinity" and "high capacity" as conceptions in the interaction of amino acids with synaptic membranesP Lähdesmäki, I Pesonen, E Kumpulainen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of metastatic carcinoid tumour with recombinant interferon alfaH Joensuu, E Kumpulainen, P Gröhn
Acta Physiologica Scandinavica|March 1, 1982
Exchange of isethionate between blood and tissues in adult and 7-day-old miceE Kumpulainen, I Pesonen, P Lähdesmäki
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Response of medullary thyroid cancer to low-dose alpha-interferon therapyP Gröhn, E Kumpulainen, M Jakobsson
Pageof 4